Phase 2 of coronavirus vaccine human trials may begin in spring – CNBC
CNBC reports that a phase 2 of coronavirus vaccine human trials may begin in spring, Moderna chairman says, resultant to out a specific date on things as it is a very dynamic situation.
CNBC's Key points
- The first human trial of a vaccine to prevent the new coronavirus could advance to the next step this spring, Moderna Chairman Noubar Afeyan said Thursday.
- “We’ll enter hopefully phase 2 trials, we expect that to happen in the spring, perhaps early summer,” Afeyan told CNBC’s Meg Tirrell.
- “It’s difficult to put a specific date on things just because it’s a very dynamic situation,” he added.
EUR/USD price analysis
The EUR/USD pair is pressuring the 61.8% retracement of its latest bullish run, maintaining its negative bias ahead of the Asian opening. In the 4-hour chart, the pair is extending its slide below all of its moving averages, with the 20 SMA moving below the larger ones, although all of them still confined to a tight range. Technical indicators in the mentioned chart stand at daily lows although losing their bearish strength. Anyway, the risk remains skewed to the downside, with the market looking to re-test the yearly low at 1.0635
– Valeria Bednarik, Chief Analyst at FXStreet explained.
Author
Ross J Burland
FXStreet
Ross J Burland, born in England, UK, is a sportsman at heart. He played Rugby and Judo for his county, Kent and the South East of England Rugby team.
